Home / Products / Cancer (Tumor) Cell Lines / NCI-H647
NCI-H647
Datasheet Protocol

NCI-H647

Cat. No. ARC0647
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Lung

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

NCI-H647 is a cancer cell line of lung adenosquamous carcinoma, isolated from metastatic; pleural effusion.

Recommended Products

Yme1l1 Knockout HL-1 Cell Line Yme1l1 Knockout HL-1 Cell Line Cat. No. ARG44224 LRRFIP1 Knockout HT29 Polyclonal Cells LRRFIP1 Knockout HT29 Polyclonal Cells Cat. No. ARG14590 EIF2D Knockout Hela Polyclonal Cells EIF2D Knockout Hela Polyclonal Cells Cat. No. ARG40998 EGFR Knockout HEK293 Polyclonal Cells EGFR Knockout HEK293 Polyclonal Cells Cat. No. ARG40735 COPS7A Knockout 786-O Polyclonal Cells COPS7A Knockout 786-O Polyclonal Cells Cat. No. ARG5452 Sheep Type II Alveolar Epithelial Cell Medium Sheep Type II Alveolar Epithelial Cell Medium Cat. No. ARM0948
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Lung
Disease:
Adenosquamous carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
56 years
Sex of Donor:
Male
Derived From Site:
Metastatic; Pleural effusion
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

NEK2 Knockout UMUC-3 Polyclonal Cells

NEK2 Knockout UMUC-3 Polyclonal Cells

Cat. No. ARG11249
 ALPK2 Knockout A549 Polyclonal Cells

ALPK2 Knockout A549 Polyclonal Cells

Cat. No. ARG19922
 IPO4 Knockout MES-OV Polyclonal Cells

IPO4 Knockout MES-OV Polyclonal Cells

Cat. No. ARG24646
 HAX1 Knockout CAL27 Polyclonal Cells

HAX1 Knockout CAL27 Polyclonal Cells

Cat. No. ARG34559
 CRTC3 Knockout Raji Polyclonal Cells

CRTC3 Knockout Raji Polyclonal Cells

Cat. No. ARG1424
 FADU Luciferase Stable Cell Line

FADU Luciferase Stable Cell Line

Cat. No. ARG0234